Research Diagnosis Related Groups (DRG) level LOS quality outcomes for North Shore University Hospital located at 300 Community Drive, Manhasset, NY, 11030 & includes data from NPIs 1952317711, 1366459570, 1295742468
Dexur analyzed Q3 2019 (July to September 2019) Medicare claims data to benchmark length of stay (LOS) outcomes for North Shore University Hospital compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jul 2019 to Sep 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 4,209 | 3,990 | ||||||||||
Surgical | 1,360 | 1,329 | ||||||||||
Non Surgical | 2,849 | 2,661 | ||||||||||
Cardiovascular | 1,121 | 1,081 | ||||||||||
General Medicine | 670 | 601 | ||||||||||
Orthopedics | 522 | 507 | ||||||||||
Gastroenterology & Endocrinology | 380 | 366 | ||||||||||
Urology | 326 | 320 | ||||||||||
Neurology | 275 | 250 | ||||||||||
General Surgery | 266 | 249 | ||||||||||
Pulmonology | 236 | 223 | ||||||||||
Oncology & Hematology | 154 | 139 | ||||||||||
Spine | 73 | 73 | ||||||||||
Psychiatry & Mental Disorders | 62 | 60 | ||||||||||
Colorectal | 60 | 58 | ||||||||||
Dermatology | 27 | 26 | ||||||||||
Obstetrics & Gynecology | 25 | 25 | ||||||||||
Obesity, Bariatric, Stomach & Duodenal | 12 | 12 |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jul 2019 to Sep 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
Heart Failure And Shock | ||||||||||||
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 293: HEART FAILURE AND SHOCK WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Syncope And Collapse | ||||||||||||
DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
Percutaneous Intracardiac Procedures | ||||||||||||
DRG 274: PERCUTANEOUS INTRACARDIAC PROCEDURES W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Acute Myocardial Infarction | ||||||||||||
DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Circulatory System Diagnoses | ||||||||||||
DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 315: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Permanent Cardiac Pacemaker Implant | ||||||||||||
DRG 244: PERMANENT CARDIAC PACEMAKER IMPLANT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 243: PERMANENT CARDIAC PACEMAKER IMPLANT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Chest Pain | ||||||||||||
DRG 313: CHEST PAIN | ||||||||||||
Endovascular Procedures | ||||||||||||
DRG 267: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 266: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
DRG 219: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Peripheral Vascular Disorders | ||||||||||||
DRG 300: PERIPHERAL VASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Vascular Procedures | ||||||||||||
DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Coronary Bypass | ||||||||||||
DRG 235: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 233: CORONARY BYPASS WITH CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Major Cardiovascular Procedures | ||||||||||||
DRG 270: OTHER MAJOR CARDIOVASCULAR PROCEDURES W MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Cardiothoracic Procedures | ||||||||||||
DRG 229: OTHER CARDIOTHORACIC PROCEDURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cardiac Defibrillator Implant | ||||||||||||
DRG 227: CARDIAC DEFIBRILLATOR IMPLANT WITHOUT CARDIAC CATHETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Hypertension | ||||||||||||
Percutaneous Cardiovascular Procedures Without Coronary Artery Stent | ||||||||||||
DRG 251: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITHOUT CORONARY ARTERY STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jul 2019 to Sep 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cellulitis | ||||||||||||
DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Signs And Symptoms | ||||||||||||
DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Complications Of Treatment | ||||||||||||
DRG 920: COMPLICATIONS OF TREATMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Factors Influencing Health Status | ||||||||||||
DRG 951: OTHER FACTORS INFLUENCING HEALTH STATUS | ||||||||||||
Disequilibrium | ||||||||||||
DRG 149: DYSEQUILIBRIUM | ||||||||||||
Postoperative And Post-Traumatic Infections | ||||||||||||
DRG 862: POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jul 2019 to Sep 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Medical Back Problems | ||||||||||||
DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 551: MEDICAL BACK PROBLEMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Hip And Femur Procedures Except Major Joint | ||||||||||||
DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 482: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Fracture, Sprain, Strain And Dislocation Except Femur, Hip, Pelvis And Thigh | ||||||||||||
DRG 563: FRACTURE SPRAIN, STRAIN AND DISLOCATION EXCEPT FEMUR, HIP, PELVIS AND THIGH WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Fractures Of Hip And Pelvis | ||||||||||||
DRG 536: FRACTURES OF HIP AND PELVIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Pathological Fractures And Musculoskeletal And Connective Tissue Malignancy | ||||||||||||
Bone Diseases And Arthropathies | ||||||||||||
DRG 554: BONE DISEASES AND ARTHROPATHIES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Lower Extremity And Humerus Procedures Except Hip,Foot,Femur |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jul 2019 to Sep 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
G.I.Hemorrhage | ||||||||||||
DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Digestive System Diagnoses | ||||||||||||
DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 393: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
G.I. Obstruction | ||||||||||||
DRG 388: G.I. OBSTRUCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 390: G.I. OBSTRUCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Disorders Of Biliary Tract | ||||||||||||
DRG 446: DISORDERS OF THE BILIARY TRACT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Diabetes | ||||||||||||
DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Cholecystectomy | ||||||||||||
Endocrine Disorders | ||||||||||||
Disorders Of Pancreas Except Malignancy | ||||||||||||
DRG 439: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Major Gastrointestinal Disorders And Peritoneal Infections |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jul 2019 to Sep 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Kidney And Urinary Tract Infections | ||||||||||||
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Renal Failure | ||||||||||||
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Kidney And Urinary Tract Diagnoses | ||||||||||||
DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Kidney And Ureter Procedures | ||||||||||||
DRG 661: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 660: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Kidney Transplant | ||||||||||||
DRG 652: KIDNEY TRANSPLANT |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jul 2019 to Sep 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
Seizures | ||||||||||||
DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Traumatic Stupor And Coma, Coma < 1 Hour | ||||||||||||
DRG 086: TRAUMATIC STUPOR AND COMA, COMA <1 HOUR WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Degenerative Nervous System Disorders | ||||||||||||
DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Disorders Of Nervous System | ||||||||||||
DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Transient Ischemia | ||||||||||||
DRG 069: TRANSIENT ISCHEMIA | ||||||||||||
Nonspecific Cerebrovascular Disorders |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jul 2019 to Sep 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Craniotomy And Endovascular Intracranial Procedures | ||||||||||||
DRG 025: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 027: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Peripheral And Cranial Nerve And Other Nervous System Procedures | ||||||||||||
DRG 041: PERIPHERAL, CRANIAL NERVE AND OTHER NERVOUS SYSTEM PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) OR PERIPHERAL NEUROSTIMULATOR | ||||||||||||
Hernia Procedures | ||||||||||||
Non-Extensive Procedure Unrelated To Principal Diagnosis | ||||||||||||
Peritoneal Adhesiolysis |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jul 2019 to Sep 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Respiratory Infections And Inflammations | ||||||||||||
DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 178: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Simple Pneumonia And Pleurisy | ||||||||||||
DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Chronic Obstructive Pulmonary Disease | ||||||||||||
DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Pulmonary Embolism | ||||||||||||
DRG 176: PULMONARY EMBOLISM WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Major Chest Trauma | ||||||||||||
DRG 184: MAJOR CHEST TRAUMA WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Respiratory System Diagnosis With Ventilator Support | ||||||||||||
DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | ||||||||||||
Bronchitis And Asthma | ||||||||||||
DRG 202: BRONCHITIS AND ASTHMA WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jul 2019 to Sep 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Red Blood Cell Disorders | ||||||||||||
DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 811: RED BLOOD CELL DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Malignancy Of Hepatobiliary System Or Pancreas | ||||||||||||
DRG 435: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Digestive Malignancy | ||||||||||||
Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||
DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | ||||||||||||
Nervous System Neoplasms | ||||||||||||
DRG 054: NERVOUS SYSTEM NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Coagulation Disorders | ||||||||||||
DRG 813: COAGULATION DISORDERS |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jul 2019 to Sep 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Spinal Fusion Except Cervical | ||||||||||||
DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cervical Spinal Fusion | ||||||||||||
DRG 472: CERVICAL SPINAL FUSION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Back And Neck Procedures, Except Spinal Fusion, Or Disc Devices/Neurostimulators | ||||||||||||
Combined Anterior/Posterior Spinal Fusion |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jul 2019 to Sep 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Psychoses | ||||||||||||
DRG 885: PSYCHOSES | ||||||||||||
Organic Disturbances And Intellectual Disability | ||||||||||||
DRG 884: ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY | ||||||||||||
Alcohol/Drug Abuse Or Dependence |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jul 2019 to Sep 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Small And Large Bowel Procedures | ||||||||||||
DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Jul 2019 to Sep 2019) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Trauma To The Skin, Subcutaneous Tissue And Breast | ||||||||||||
DRG 605: TRAUMA TO THE SKIN, SUBCUTANEOUS TISSUE AND BREAST WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |